Xia et al. showed that bergenine may be a promising drug candidate for treating liver fibrosis because it activated PPARγ, inhibited TGF-β, and reduced liver fibrosis by inhibiting hepatocyte necrosis and extracellular matrix formation [183]. This evidence concerns the gene PPARG and Hepatic fibrosis.